News

Senate committee report highlights a lack of visibility in API suppliers.

Amid continued tussling over drug costs, a new working group will review the government’s authority to revoke licenses for medical products.

Pharma Commerce offers a synopsis of some of the conference’s events.

Industry is still scrambling to handle clerical errors of DSCSA transactions.

Event—taking place in Indianapolis—places supply chain education at the forefront.

The Pulse online service will provide free resources to enable pharmacy to meet drug traceability rules.

Q&A explores new opportunities to strengthen supply chain resilience—and build on the lessons learned.

Project addresses customer demand in GMP-powered advanced therapeutics.

In an effort to strengthen supply chain, unnamed pharma company to use chain of custody application to combat an illegal global market worth up to $200 billion annually.

Acquisition expands company’s eCTD submission capabilities.

Latest investigation signals more scrutiny of pharmacy benefit managers and their role in treatment cost and coverage.

The deal—potentially totaling upwards of $100 million—strengthens the company’s selection of US generic prescription products.

Stats point to a 14.9% decline compared to January of last year.

Initiative intends to facilitate regulatory compliance within the pharma distribution space.

With the help of traceability, new feature prioritizes efficiency and safety, from production to patient.

Hoping to accelerate the drug delivery process, production is expected to begin as early as 2025.

Following numerous successful trial runs, vaccine production is expected to reach 700 million.

Expansion expected to increase global capacity by 75%.

Enhancements to help keep products frozen for over 144 hours, company says.

Joint venture revolves around around the use of raw materials for the development—and ultimately commercialization—of therapies.

New 25,000 square-foot facility will help grow customers’ gene therapy programs.

Site expected to support growth of advanced analytics and data science team.

Pharma sector, FMI report says, is quickly growing, due to globalization and development of low-cost medications.

Facility addition expected to increase production capacity of TNAs.

Investment helps encourage sustainability in the space, especially as it pertains to pharma, company says.

cGMP line will fill vials, syringes, and cartridges, while supporting small-scale commercial production.

Conclusion driven by various factors, including product shortages and cost pressures.

Flights from Colombia and Ecuador more than doubled during the season, resulting in exports of nearly 18,000 tons.